Systemic Administration of Allogeneic Mesenchymal Stem Cells Does Not Halt Osteoporotic Bone Loss in Ovariectomized Rats.

Mesenchymal stem cells (MSCs) have innate ability to self-renew and immunosuppressive functions, and differentiate into various cell types. They have become a promising cell source for treating many diseases, particular for bone regeneration. Osteoporosis is a common metabolic bone disorder with ele...

Full description

Bibliographic Details
Main Authors: Shuo Huang, Liangliang Xu, Yuxin Sun, Sien Lin, Weidong Gu, Yamei Liu, Jinfang Zhang, Lin Chen, Gang Li
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5053541?pdf=render